The Complete Peptide Therapy Starter Guide: From First Question to First Injection

How to Start Peptide Therapy: The Short Answer

You start peptide therapy by getting your baseline labs done, consulting a licensed clinician who can evaluate your metabolic and hormonal profile, and receiving a protocol built specifically around your biology. You do not start by ordering peptides online. You do not start by copying someone else's dosing schedule from a forum. The order matters — and getting it wrong costs you results, or worse, your safety.

This guide covers everything you need to know before your first injection: what peptide therapy actually is, which peptides beginners encounter most, how to find a legitimate provider, what your first protocol will look like, and what to watch for along the way.

What Is Peptide Therapy — and Why Is It Growing?

Peptide therapy uses short chains of amino acids — peptides — to signal specific biological processes in the body. These are not hormones. They are messengers that tell your body to do something it already knows how to do: produce more growth hormone, repair tissue, regulate appetite, or improve insulin sensitivity.

This is a meaningful distinction. Hormones replace. Peptides signal. That difference shapes the safety profile and the clinical reasoning behind using them.

Interest in peptide therapy has grown sharply over the past decade. Much of it traces to the mainstream adoption of GLP-1 receptor agonists — semaglutide and tirzepatide — which are technically peptide-based drugs. But the clinical interest stretches far beyond GLP-1s. Researchers and clinicians are now using peptides to address growth hormone deficiency, visceral fat accumulation, tissue recovery, sexual dysfunction, and metabolic syndrome.

The appeal is specificity. A well-selected peptide acts on a narrow biological target. That narrow action is what makes the therapy useful — and what makes protocol selection so important.

How to Start Peptide Therapy: 6 Steps in the Right Order

Starting peptides safely is not complicated. But it requires a specific sequence. Skip steps, and you are not optimising your results — you are gambling with them.

Step 1: Define Your Goal Precisely

Peptide therapy is not a single intervention. It is a category of interventions, each with different mechanisms, evidence levels, and clinical applications.

Before you talk to a provider, you need to know what you are trying to address. Common clinical goals include:

• Fat loss / body composition — particularly visceral fat reduction
• Growth hormone optimisation — for energy, recovery, sleep quality, and muscle preservation
• Metabolic function — improving insulin sensitivity and reducing metabolic syndrome markers
• Sexual health — addressing low libido or hormonal dysfunction
• Tissue repair — recovery from injury, gut lining integrity, inflammation

Your goal determines which peptide class is appropriate. If you walk into a consultation without clarity here, you are more likely to receive a generic protocol rather than one calibrated to your physiology. Read 6 Signs Your Growth Hormone May Be Low if you are unsure whether GH optimisation applies to you.

Step 2: Get Baseline Labs Before Anything Else

This step is non-negotiable. Baseline labs do three things: they reveal what is actually dysregulated in your body, they establish reference points to measure against during therapy, and they screen for contraindications that would make certain peptides unsafe.

The specific labs you need depend on your goal, but a general metabolic baseline typically includes:

Meto's Growth Hormone Peptide Therapy Labs guide covers every test worth ordering before starting a GH secretagogue protocol, including what your results mean and which numbers should concern you.

If you want a comprehensive starting point, Meto's Comprehensive Metabolic Panel — which covers HbA1c, fasting glucose and insulin, lipids, CMP, liver markers, and inflammatory markers — is purpose-built for this kind of pre-treatment assessment.

Step 3: Consult a Clinician Who Understands Metabolic Medicine

This is where most people get stuck. General practitioners often have limited familiarity with peptide protocols. Functional medicine providers vary widely in rigour. And the internet is full of providers willing to prescribe with no labs required — which is a red flag, not a convenience.

You need a clinician who:

• Reviews your labs before prescribing, not after
• Can explain the mechanism of the peptide they are recommending
• Has a monitoring plan built into the protocol from day one
• Will not prescribe peptides that have no human clinical evidence

Telehealth has made this more accessible. Platforms like Meto connect you with metabolic specialists who review your full profile before making any treatment recommendation. See the Peptide Therapy Providers in 2026 Compared guide for a detailed breakdown of what to look for — and what to avoid — when evaluating a provider.

Step 4: Understand Your Protocol Before You Agree to It

A legitimate clinician will explain your protocol to you. Not just the name of the peptide and the dose — the mechanism, the expected timeline, what side effects are plausible, and what results would justify continuing versus stopping.

Before you begin, you should be able to answer:

• What does this peptide do at a biological level?
• How long before I should expect to notice anything?
• What are the most common side effects and how do I manage them?
• What labs will we recheck, and when?
• What is the plan if I do not respond as expected?

If your provider cannot answer these questions, that is clinical data. Find a different provider.

The Peptide Therapy Side Effects FAQ covers 15 of the most common questions patients ask about risks, interactions, and contraindications. Read it before your first consultation.

Step 5: Source From a Licensed 503A or 503B Compounding Pharmacy

Peptide sourcing is where safety breaks down most often. The majority of peptides in common clinical use — BPC-157, CJC-1295, ipamorelin, and others — are not available as commercially manufactured pharmaceutical products. They are compounded.

Compounding is legal and clinically common in the United States. But not all compounders are equal.

• 503A pharmacies compound for individual patients based on a valid prescription. They operate under state pharmacy board oversight.
• 503B outsourcing facilities compound in larger quantities under federal FDA oversight and Current Good Manufacturing Practice (cGMP) standards, which provides an additional layer of quality assurance.

You should never source peptides from research chemical suppliers, grey-market websites, or any supplier that does not require a prescription. These products are not manufactured to pharmaceutical standards, are not tested for potency or sterility, and carry real contamination risks.

Your prescribing clinician should be coordinating your prescription directly with a licensed compounding pharmacy. If they are not, ask why.

Step 6: Learn Proper Injection Technique

Most clinical peptides are delivered subcutaneously — injected into the fatty tissue just below the skin, typically in the abdomen. It sounds daunting. In practice, subcutaneous injections are straightforward, low-pain, and easy to learn.

Your first injection should be supervised or accompanied by detailed instruction from your clinical team. Key principles:

• Rotate injection sites to prevent lipohypertrophy (fatty tissue buildup at repeated injection points)
• Use appropriate needle gauge (typically 29–31G for subcutaneous injection)
• Inject at the correct angle (45–90 degrees depending on tissue depth)
• Reconstitute lyophilised peptides correctly with bacteriostatic water — the ratio matters
• Store reconstituted peptides refrigerated and within the stability window specified by your pharmacy

Improper storage or reconstitution degrades peptide potency. Your pharmacist and clinician should walk you through this. Do not skip this conversation.

Which Peptides Do Beginners Most Often Encounter?

Not every peptide is appropriate for every patient. Here is a structured overview of the most commonly prescribed peptides for first-time patients, organised by clinical goal.

Beginners in a peptide therapy guide for beginners context most often start with one of two entry points: a GLP-1 receptor agonist for metabolic and weight goals, or a growth hormone secretagogue stack (CJC-1295/ipamorelin being the most common) for body composition and recovery. More complex stacks — like the KLOW stack — are second- or third-tier considerations once the patient has established tolerability and response.

For women dealing with hormonal and metabolic overlap — particularly those with PMOS — the clinical picture is more nuanced. The Peptide Therapy for PMOS deep-dive covers which peptides have human evidence for this population and which do not. See also 8 Peptides Being Studied for Women's Hormonal and Metabolic Health in 2026 for current research context.

How to Start Peptide Therapy Safely: Green Lights and Red Flags

A critical part of starting peptides safely is knowing the difference between a legitimate clinical environment and a commercial one dressed up to look clinical.

Green lights — signs you are in a safe, medically sound process:

• Your provider reviewed your labs before prescribing
• The prescription goes to a licensed 503A or 503B compounding pharmacy
• You have a scheduled follow-up for lab reassessment within 8–12 weeks
• Side effects and contraindications were discussed proactively
• The protocol has a defined duration and a stated goal with measurable outcomes

Red flags — walk away:

• Peptides offered without a prescription or lab review
• Dosing schedules copied directly from bodybuilding forums with no clinical adaptation
• Providers who cannot explain the mechanism of the peptide they are prescribing
• No plan for monitoring after initiation
• Products sourced from research chemical suppliers

This matters more than most patients realise. Unregulated peptide products have been found to contain incorrect concentrations, bacterial contamination, and, in some cases, entirely different compounds than labelled.[^1]

What to Expect in Your First 12 Weeks

Timelines vary by peptide class and individual response. Here is a realistic framework for a first-timer on a GH secretagogue protocol — the most common beginner scenario.

Weeks 1–2: Adaptation Side effects, if they occur, are most common here. Injection site reactions (mild redness, transient soreness) are normal. Water retention is possible with some GH peptides. Sleep often improves early — this is one of the first signals the protocol is working.

Weeks 3–6: Early physiological changes Energy and sleep quality tend to improve in this window. Recovery from exercise becomes noticeably faster for many patients. Body composition changes are not yet visible on the scale but are beginning at the tissue level.

Weeks 7–12: Measurable progress This is when lab reassessment becomes meaningful. IGF-1 should have shifted. Fasting insulin may have improved if metabolic support was a goal. Body composition changes — typically reduction in visceral fat and preservation or improvement in lean mass — become more apparent.

For a detailed, biomarker-by-biomarker breakdown of what real results look like at 12 weeks, read What 12 Weeks of Growth Hormone Peptide Therapy Results Look Like in a Metabolic Patient. It walks through actual lab data — IGF-1, HOMA-IR, triglycerides, and fasting insulin — from a documented clinical case.

Who Should NOT Start Peptide Therapy?

Peptide therapy is not appropriate for everyone. Clinical contraindications exist and should be screened for before any protocol begins.

Absolute contraindications:

• Active malignancy or history of cancer sensitive to growth-promoting signals (e.g., certain GH-dependent tumours)
• Pregnancy or breastfeeding
• Untreated or uncontrolled diabetes
• Active hypoglycaemia risk without supervision

Relative contraindications requiring careful clinical assessment:

• Significant renal or hepatic impairment (clearance is affected)
• Active autoimmune conditions
• History of hypersensitivity to peptide compounds
• Severe cardiovascular disease

The Peptide Therapy Side Effects FAQ covers medication interactions in detail, including what to disclose to your clinician about current medications before starting any peptide protocol.

If you are dealing with a condition like metabolic syndrome or are on medications for insulin resistance, thyroid function, or hormonal therapy, these must all be factored into your protocol design — not disclosed as an afterthought.

The Role of Metabolic Context: Why This Is Not Just About Peptides

The patients who get the best results from peptide therapy are not the ones on the most aggressive protocols. They are the ones who arrived with the clearest picture of their metabolic baseline.

A peptide cannot fix a lifestyle it cannot work with. A GH secretagogue will not produce meaningful body composition change in a patient with uncontrolled insulin resistance — because elevated insulin suppresses GH pulsatility regardless of the secretagogue signal.[^2] A GLP-1 agonist will produce meaningful early weight loss, but the metabolic improvement is compounded by concurrent dietary and lifestyle management, not replaced by it.

This is why metabolic context matters before, during, and after any peptide protocol. It is also why Meto's approach — combining lab-guided assessment with specialist-led care across weight loss, metabolic syndrome, hormonal health, and peptide therapy — produces outcomes that are sustainable rather than episodic.

If you are considering peptides as part of a broader metabolic plan, Peptides for Metabolic Syndrome is essential reading. It covers the clinical framework for selecting the right therapy when multiple metabolic pathways are involved — and includes a comparison table of peptide mechanisms against metabolic syndrome markers.

How Meto Approaches Peptide Therapy

Meto is not a peptide shop. It is a metabolic and hormonal health platform that includes peptide therapy within a supervised, lab-guided clinical model — where appropriate.

When you start with Meto, the process follows the same sequence outlined in this guide:

1. Online health assessment — symptoms, goals, medication history, and relevant background
2. Lab panel — ordered before treatment, not alongside it
3. Clinician review — a specialist with metabolic expertise evaluates your full picture
4. Personalised protocol — built around your biology and your goal, not a generic template
5. Ongoing monitoring — labs are rechecked on a defined schedule; protocols are adjusted based on data

The assessment takes minutes. The lab review happens within your first clinical visit. The protocol you receive is grounded in your specific numbers, not a population average.

If you are ready to understand your metabolic baseline and explore whether peptide therapy is clinically appropriate for you — start here.

Conclusion

Knowing how to start peptide therapy means knowing what order to follow. Get clear on your goal. Get your baseline labs. Work with a licensed clinician. Understand your protocol. Source from a legitimate pharmacy. Learn your injection technique. Then follow your protocol, track your response, and reassess with data.

This is not a complicated process. But every shortcut has a cost — in results, in safety, or in both.

The patients who get the most from peptide therapy are the ones who treated it as a medical intervention, not a supplement stack. That starts with the right information and the right clinical team behind it.

Frequently Asked Questions

Do I need a prescription to start peptide therapy?

Yes — in the United States and most developed countries, peptide therapies prescribed for clinical use require a valid prescription from a licensed healthcare provider. Peptides sourced without a prescription have not been manufactured to pharmaceutical standards, are not subject to quality testing, and carry real risks of contamination, incorrect concentration, or mislabelling. A prescription also ensures your protocol is clinically supervised.

How long does it take to see results from peptide therapy?

It depends on the peptide and the goal. Growth hormone secretagogues typically show measurable IGF-1 changes within 8–12 weeks. Sleep and recovery improvements often appear within the first 2–4 weeks. GLP-1 receptor agonists can show meaningful weight and glucose changes within 4–8 weeks. Body composition changes — visible lean mass and fat reductions — generally take a full 12-week cycle to assess properly.

Can I combine peptides — for example, BPC-157 with a GH secretagogue?

Peptide stacking is done clinically, but it requires more rigour — not less — than a single-peptide protocol. Your clinician needs to understand the mechanisms of both compounds, confirm there are no overlapping risks, and build a monitoring plan that covers both. Stacks are not appropriate for first-time patients until tolerability on a single peptide is established. Never stack peptides based on forum recommendations alone.

Are peptide therapy side effects serious?

Most peptide side effects reported in supervised clinical settings are mild and transient — injection site reactions, temporary water retention, increased hunger, or initial fatigue. Serious adverse events are uncommon when peptides are properly sourced, correctly dosed, and clinically monitored. The most significant risks arise from unsupervised use, incorrect dosing, or peptides sourced from unregulated suppliers. The full side effect profile varies meaningfully by peptide class. See the Peptide Therapy Side Effects FAQ for detailed coverage.

How do I know if peptide therapy is right for me?

Peptide therapy is most likely appropriate when you have a specific, measurable clinical goal — growth hormone optimisation, visceral fat reduction, metabolic dysfunction, sexual health — and a baseline lab panel that supports the use of a targeted intervention. It is not appropriate as a general wellness supplement or as a shortcut to results that lifestyle change alone could produce. A metabolic specialist can tell you whether your labs and goals align with a clinical indication — that is the right starting point.

Is peptide therapy covered by insurance?

Coverage depends on the specific peptide and the clinical indication. FDA-approved peptides prescribed for approved indications — such as tesamorelin for HIV-associated lipodystrophy or bremelanotide for female sexual desire disorder — may attract coverage in some plans. Most growth hormone secretagogues and off-label peptide protocols are not typically covered. Meto works with major insurance providers for its broader metabolic care programmes; start your online assessment to get a personalised cost estimate based on your coverage.